DiscoverAll Things PolicyEp. 622: Tackling Mis/Disinformation on Vaccines
Ep. 622: Tackling Mis/Disinformation on Vaccines

Ep. 622: Tackling Mis/Disinformation on Vaccines

Update: 2021-07-22
Share

Description

Only around 6% of Indians have been fully vaccinated. While there are supply-side constraints, demand-side bottlenecks such as vaccine hesitancy are a challenge. With a new virus variant hitting several countries, vaccine hesitancy in a vast country like India can reverse the gains made in the past few months. One of the factors that are driving vaccine hesitancy is incorrect information about the efficacy of vaccines and its side effects.

Kamesh Shekar and Apurva Kumar discuss how mis/disinformation leads to vaccine hesitancy and what steps can be taken to address the problem.

Kamesh is a technology & policy researcher. He is currently pursuing his PGP in Public Policy at Takshashila Institution. His research interests are data protection, intermediary liability, issue of mis/disinformation on social media, AI in media, etc. You can read his work here- https://kameshsshekar.in/writing/

Further readings:

If these All Things Policy conversations interest you, consider applying for Takshashila's courses. Admissions are now open and the application deadline for our upcoming cohort is 28th August, 2021.

Find out about our courses over here - https://bit.ly/ATP-GCPP 

Follow Kamesh Shekar on Twitter - https://twitter.com/kameshsshekar?s=20

Follow Apurva Kumar on Twitter - https://twitter.com/apurva_kr?s=20

You can listen to this show and other awesome shows on the IVM Podcasts app on Android: https://ivm.today/android or iOS: https://ivm.today/ios, or any other podcast app


See omnystudio.com/listener for privacy information.

Comments 
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Ep. 622: Tackling Mis/Disinformation on Vaccines

Ep. 622: Tackling Mis/Disinformation on Vaccines

IVM Podcasts